Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

185 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer

NCT04827953

Conditions
Pancreatic Ductal Adenocarcinoma
Locations
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Universitario Virgen De La Victoria Málaga, Andalusia, Spain
  • Hospital Universitario Miguel Servet Zaragoza, Aragon, Spain
  • Hospital Universitario Donostia Donostia / San Sebastian, Basque Country, Spain
View Trial Details
Completed

A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

NCT05867121

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations
  • UCLA University of California Los Angeles Los Angeles, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • St Vincent'S Hospital Darlinghurst, New South Wales, Australia
View all 27 locations
View Trial Details

Related conditions